These findings identify a novel mechanism of increased ATGL-mediated LDs utilization in colon cancer progression and establish a platform for new diagnostic and therapeutic importance in colonic tumorigenesis, especially when driven by obesity. The gene discussed is PNPLA2; the disease is obesity due to melanocortin 4 receptor deficiency.